Vira Regen Inc. is a regenerative medicine company pioneering gene-specific bioelectronic medicines that directly activate the body’s innate repair programs. By precisely modulating the bioelectric network to control molecular genetic pathways, Vira Regen’s electroceutical platform accelerates tissue regeneration and functional recovery.

The company is initially focused on high-burden skeletal and musculoskeletal conditions—including bone fractures, nonunions, osteoarthritis, osteoporosis, and bone cancer—where current therapies fail to address the underlying biology.

Vira Regen’s approach targets the root causes of injury and disease, enabling faster, more complete healing through the body’s own self-repair mechanisms.